Abstract Systemic lupus erythematosus (SLE) is a multisystem autoimmune connective tissue disorder characterized by various aberrations including increased production of IL-18. As IL-18 105 A>C polymorphic variants have been linked to increased production of this cytokine, we investigated the prevalence of IL-18 105 A>C (rs549908) polymorphic variants in SLE patients (n = 111) and controls (n = 152). There were no signiWcant diVerences in the distribution of IL-18 105 A>C polymorphic variants in SLE patients and controls. However, there was a signiWcant association between the IL-18 105 AA genotype (recessive model) and renal manifestations OR = 3.360 (1.523-7.415, P = 0.0039) and the P value remained statistically signiWcant after Bonferroni correction (P corr = 0.0351).Our Wndings indicate that the IL-18 105 AA genotype variant can contribute to renal manifestations in patients with SLE.
Introduction
Systemic lupus erythematosus (SLE) is a multisystem autoimmune connective tissue disorder characterized by loss of self-tolerance causing immune-mediated tissue destruction and various clinical presentations [1, 2] . Defective function of CD4 + T cells and abnormal activation of B cells results in autoantibody production and immune complex formation [3] [4] [5] .
Immune cells from SLE patients display various aberrations including abnormal cytokine production, reduction of cytotoxic T cell function, and enhancement of humoral response [3] [4] [5] [6] [7] .
Interleukin-18 (IL-18) belongs to a pleiotropic proinXammatory cytokine that contributes to the cellular and humoral immune response [8] , both innate and adaptive [9] . IL-18 induces biosynthesis of IFN-, TNF-, IL-1, IL-2, as well as expression of adhesion proteins leading to increase in T lymphocyte proliferation [8, 9] . This cytokine also promotes the lytic activity of NK-cells [8, 9] . IL-18 can contribute to the pathogenesis of various disorders including liver cirrhosis, type I diabetes, rheumatoid arthritis, Crohn's disease, and SLE [10] [11] [12] [13] [14] [15] [16] . It has been reported that IL-18 concentrations are signiWcantly higher in blood plasma of SLE patients than in control subjects [14] [15] [16] .
The signiWcance of susceptibility genes in SLE incidence has been heavily researched. Many genes that encode proteins involved in the immune system have been designated as candidate susceptibility genes [17] [18] [19] [20] [21] .
Investigation has revealed the relationship between IL-18 gene polymorphic variants and predisposition to various malignant viral and autoimmune diseases [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Recently, a signiWcant association was found between SLE and the IL-18 105 A>C (rs549908) polymorphic variants [32] .
Although this polymorphism does not result in amino acid changes, individuals with IL-18 AA, AC and CC genotypes diVer in production of this cytokine [34] . Therefore, we analyzed the distribution of IL-18 105 A>C polymorphic variants in SLE patients (n = 111) and controls (n = 152).
Patients and methods

Patients and controls
Data for 111 patients (women only) fulWlling the American College of Rheumatology ClassiWcation (ACRC) criteria for SLE [35, 36] were collected for investigation at Institute of Rheumatology Warsaw, Poland. The controls constituted of 152 healthy women of Polish Caucasian origin, enrolled from individuals who had a comprehensive examination at the Institute of Mother and Child in Warsaw.
The protocol of the study was approved by the Local Ethical Committee of Poznaj University of Medical Sciences. Written consent was obtained from all participating subjects. Both patients and control groups were of Polish Caucasian origin. The mean age of SLE patients at diagnosis was 38 § 11 years, and the mean age of controls 37 § 12 years.
Genotyping DNA was isolated from peripheral blood lymphocytes by salt extraction. Polymorphic variants of IL-18 105 A>C (rs549908) were identiWed using PCR with the primer pair 5Ј-GTT TAT TGT AGA AAA CCT GGA ATT 3Ј and 5Ј-ACC CCT AGC AAT GTC TTA TTG-3Ј followed by TagI (T/CGA) restriction digestion. The underlined letter denotes the modiWed base necessary for the creation of this speciWc restriction site. The 105 C allele was cleaved into 24 bp and 326 bp fragments, whereas the 105 A allele remained uncut as 350 bp. Digestion products were separated on 10% polyacrylamide gels and stained by silver method. ConWrmation of polymorphism was performed by sequencing analysis.
Statistical analysis
The distribution of genotypes in all groups was tested for deviation from Hardy-Weinberg equilibrium. Fisher exact test was used to determine diVerences in the genotypic and allelic distribution between patients and controls. Moreover, the Odds ratio (OR) and 95% conWdence intervals (CI) were calculated. A P value < 0.05 was considered statistically signiWcant. Associations between clinical manifestations and polymorphism distribution in patients with SLE were determined by Fisher exact test.
Results
Analysis of IL-18 105 A>C genotypes revealed no signiWcant deviation from Hardy-Weinberg equilibrium in any group. There was no signiWcant diVerence in the distribution of IL-18 105 A>C polymorphic variants in SLE patients and controls (Table 1) .
OR for SLE patients with the 105 AA genotype was 0.8500 (95% CI = 0.5205-1.388, P = 0.5344), and OR of the 105 AA and 105 AC genotypes was 1.410 (95% CI = 0.5757-3.452, P = 0.5130) ( Table 1) .
However, there was a signiWcant association between IL-18 105 AA genotype (recessive model) and renal manifestations OR = 3.360 (1.523-7.415, P = 0.0039), and the P value remained statistically signiWcant after Bonferroni correction (P corr = 0.0351) ( Table 2) .
Discussion
Despite increased levels of IL-18 in SLE patients, the role of IL-18 in SLE pathogenesis remains unclear [14] [15] [16] .
To date, the genetic contribution of variants in IL-18 promoter regions has been demonstrated in allergic rhinitis, asthma, as well as SLE [27] [28] [29] [30] [37] [38] [39] . Many polymorphic variants in IL-18 promoter regions inXuence expression of IL-18 and may aVect the blood plasma level of IL-18 [22, 34, 40] . It has been reported that single nucleotide polymorphisms in the IL-18 gene promoter at ¡607 C ! A and ¡137 G ! C alter the aYnity of binding sites for CREB transcriptional factors and the H4TF-1 nuclear factor [22] . The allele -137 G is associated with increases in both spontaneous and stimulated IL-18 biosynthesis [34, 40] . Results from linkage disequilibrium investigations indicate a signiWcant association between IL-18 137 G>C and IL-18 105 A>C polymorphic variants [34, 40] . Moreover, individuals bearing the IL-18 AA genotype exhibited a higher production of this cytokine than subjects bearing either the AC or CC genotype [34] . To date, the contribution of the IL-18 105 A>C polymorphism has been observed in asthma, rheumatoid arthritis, as well as in SLE. Higa et al. [33] found that the frequency of the 105 A allele was signiWcantly higher in asthmatic patients than in controls. Moreover, Lee et al. [31] observed that the IL-18 105 A allele was associated with rheumatoid arthritis in Chinese patients. The IL-18 105 A allele frequency was also signiWcantly higher in Taiwanese patients with SLE [32] .
We did not observe diVerences in the distribution of the IL-18 105 A>C polymorphism between patients with SLE and controls. However, we found a signiWcant association of renal symptoms with the IL-18 105 AA genotype.
As the IL-18 105 AA genotype is associated with increased IL-18 biosynthesis, we presume that this cytokine can be over-produced in the kidney of individuals bearing the 105 AA genotype. This increased IL-18 production may initiate or augment inXammatory events in nephritic glomeruli by attraction of immune cells.
Our hypothesis may be supported by studies recently conducted by Tucci et al. [41] , who reported increased production of IL-18 in patients with lupus nephritis. Moreover, they found that patients with severe lupus nephritis exhibit a high accumulation of IL-18 within glomeruli [41] . They suggested that IL-18 is biosynthesized by macrophages within nephritic glomeruli, and this cytokine may chemoattract plasmacytoid dendritic cells to kidney glomeruli, leading to renal damage [41] . Wong et al. [42] also reported elevated production of IL-18 in SLE patients with renal disease. Moreover, increased expression of IL-18 was observed in nephritic kidneys in lupus-prone MRL/lpr mice [43] .
However, our results are contradictory to the study of Lin et al. [32] who reported the association of IL-18 105 A>C polymorphism with SLE incidence in Taiwanese SLE patients. They also observed a signiWcantly higher A allele frequency in SLE patients with a central nervous system disorder.
The variability of the inXuence of the IL-18 105 A>C polymorphism on SLE manifestation and incidence in diVerent populations can be due to genetic heterogeneity, which usually confounds the study of multigenic disorders. Furthermore, various environmental factors together with genetic heterogeneity may also modulate the eVect of the IL-18 105 A>C polymorphism on clinical manifestations and/or incidence of SLE [44] .
However, to more precisely determine the association of the IL-18 105 A>C polymorphism to SLE incidence and/or manifestation, further investigation of the distribution of these variants in other populations is required. 
